Analysts See $0.07 EPS for Inovalon Holdings, Inc. (INOV) as of February, 19

Inovalon Holdings, Inc. (NASDAQ:INOV) Corporate Logo

Inovalon Holdings, Inc. (NASDAQ:INOV)’s earnings report is anticipated on February, 19., as reported by RTT. The earnings per share diference is $0.03 or 75.00 % up from last years number. Previous year: $0.04; Analysts forcast: $0.07. INOV’s profit could reach $10.67 million with 51.29 P/E in case $0.07 earnings per share is announced. After $0.09 EPS report last quarter, Wall Street now sees -22.22 % negative EPS growth of Inovalon Holdings, Inc.. INOV hit $14.36 during the last trading session after $0.07 change.Currently Inovalon Holdings, Inc. is downtrending after 16.29% change in last February 14, 2018. INOV has 289,956 shares volume. INOV underperformed the S&P 500 by 16.29%.

Inovalon Holdings, Inc. (NASDAQ:INOV) Ratings Coverage

In total 2 analysts cover Inovalon Holdings (NASDAQ:INOV). “Buy” rating has 0, “Sell” are 0, while 2 are “Hold”. (NASDAQ:INOV) has 0 bullish analysts. 2 are the (NASDAQ:INOV)’s ratings reports on Feb 14, 2019 according to StockzIntelligence Inc. The stock rating was maintained by Wells Fargo with “Market Perform” on Thursday, November 8. On Thursday, December 20 Morgan Stanley upgraded Inovalon Holdings, Inc. (NASDAQ:INOV) to “Equal-Weight” rating.

Inovalon Holdings, Inc., a technology company, provides cloud platforms empowering a data-driven transformation from volume to value models throughout the healthcare industry.The firm is worth $2.19 billion. The firm through, large-scale data interconnectivity capabilities, unparalleled proprietary data sets, advanced analytics, data-driven intervention systems, and industry-leading subject matter expertise, enables the assessment and improvement of clinical and quality outcomes, and financial performance across the healthcare ecosystem.Last it reported negative earnings. It serves health plans and well-known provider organizations, as well as pharmaceutical, medical device, and diagnostics companies.

For more Inovalon Holdings, Inc. (NASDAQ:INOV) news brought out briefly go to: Globenewswire.com, Seekingalpha.com, Globenewswire.com, Globenewswire.com or Globenewswire.com. The titles are as follows: “Inovalon to Participate at 2018 RBC Capital Markets Global Healthcare Conference – GlobeNewswire” brought out on February 15, 2018, “Inovalon Got It All To Show – Seeking Alpha” on September 23, 2018, “Detailed Research: Economic Perspectives on Inovalon, Merit Medical, Senseonics, Ocular Therapeutix, The Hartford Financial Services Group, and Synopsys — What Drives Growth in Today’s Competitive Landscape – GlobeNewswire” with a publish date: January 22, 2019, “Inovalon Reports Third Quarter 2018 Results Nasdaq:INOV – GlobeNewswire” and the last “HomeCare Elite Honors 166 Amedisys Home Health Care Centers – GlobeNewswire” with publication date: January 16, 2019.

Inovalon Holdings, Inc. (NASDAQ:INOV) Analyst Ratings Chart

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.